Search hospitals > Illinois > Chicago
Northwestern University
Claim this profileChicago, Illinois 60611
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Lymphoma
Conducts research for Leukemia
1949 reported clinical trials
212 medical researchers
Summary
Northwestern University is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Breast Cancer, Human Immunodeficiency Virus Infection, Lymphoma, Leukemia and other specialties. Northwestern University is involved with conducting 1,949 clinical trials across 1,900 conditions. There are 212 research doctors associated with this hospital, such as Aparna Kalyan, Sunandana Chandra, Amy Paller, and Devalingam Mahalingam, MBBChBAO.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Aparna KalyanNorthwestern University1 year of reported clinical research
Expert in Cancer
Studies Bile Duct Cancer
20 reported clinical trials
39 drugs studied
Sunandana ChandraNorthwestern University1 year of reported clinical research
Expert in Melanoma
Expert in Skin Cancer
22 reported clinical trials
31 drugs studied
Amy PallerNorthwestern University6 years of reported clinical research
Studies Atopic Dermatitis
Studies Eczema
18 reported clinical trials
17 drugs studied
Devalingam Mahalingam, MBBChBAONorthwestern University5 years of reported clinical research
Studies Solid Tumors
Studies Tumors
17 reported clinical trials
53 drugs studied
Clinical Trials running at Northwestern University
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Glioblastoma
Bladder Cancer
Renal Cell Carcinoma
Gastric Cancer
Esophageal Adenocarcinoma
Lymphoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northwestern University?
Northwestern University is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Breast Cancer, Human Immunodeficiency Virus Infection, Lymphoma, Leukemia and other specialties. Northwestern University is involved with conducting 1,949 clinical trials across 1,900 conditions. There are 212 research doctors associated with this hospital, such as Aparna Kalyan, Sunandana Chandra, Amy Paller, and Devalingam Mahalingam, MBBChBAO.
Where is Northwestern University located?
Northwestern Memorial Hospital is located at 675 N. St. Clair St., downtown Chicago, on the southeast corner of N St. Clair Street and E. Huron Street. It is a key part of the Northwestern Memorial Healthcare system, which encompasses multiple facilities and physician offices in the downtown medical campus. Patients and visitors can find parking at discounted rates with a validated ticket.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Northwestern University Hospital, contact the Financial Assistance Department at 312-926-6900 for help with insurance coverage, working with insurance companies, and obtaining estimates for self-paying patients. They offer a Financial Assistance Program (FAP) for qualifying patients to receive free or discounted care for emergency, essential, and/or medically necessary services. To apply for FAP, fill out an application with the required documents and submit it to the Patient Financial Services office. For additional support, contact the Financial Counseling Department at 800-423-0523.
What insurance does Northwestern University accept?
Northwestern University's hospitals accept a wide range of insurance plans, including commercial, government, and exchange plans. They specifically accept Blue Cross and Blue Shield of Illinois, Anthem, Blue Choice Preferred PPOSM, and Medicare Advantage HMO plans. Additionally, they accept plans with special contracting arrangements with Northwestern Medicine, offering higher payment coverage. It's advised to contact your physician’s office directly for information on accepted insurance plans, as physicians at Northwestern Medicine hospitals may accept different plans.
What awards or recognition has Northwestern University received?
Northwestern Memorial Hospital, located in Chicago, Illinois, is nationally recognized for its excellence in patient care, nursing, and commitment to LGBTQ+ healthcare equality. It has been ranked as one of the top hospitals in the nation by U.S. News & World Report and has achieved Magnet® recognition. The affiliated Northwestern University Feinberg School of Medicine ranks in the top 20, with a strong research focus underscored by receiving $477 million in NIH funding for 2022-2023, placing it 15th among American Medical Schools in NIH funding rankings.